GPR52
G-protein coupled receptor 52
Also known as: GPR52_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y2T5
- Gene
- GPR52
- Ensembl
- ENSG00000203737
- Chromosome
- 1
- Canonical length
- 361 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins
OverviewNCBI Gene
Members of the G protein-coupled receptor (GPR) family play important roles in signal transduction from the external environment to the inside of the cell.[supplied by OMIM, Jul 2002]
Canonical amino-acid sequenceUniProt
361 residues, UniProt reviewed canonical sequence.
>Q9Y2T5|GPR52
1 MNESRWTEWR ILNMSSGIVN VSERHSCPLG FGHYSVVDVC IFETVVIVLL TFLIIAGNLT
61 VIFVFHCAPL LHHYTTSYFI QTMAYADLFV GVSCLVPTLS LLHYSTGVHE SLTCQVFGYI
121 ISVLKSVSMA CLACISVDRY LAITKPLSYN QLVTPCRLRI CIILIWIYSC LIFLPSFFGW
181 GKPGYHGDIF EWCATSWLTS AYFTGFIVCL LYAPAAFVVC FTYFHIFKIC RQHTKEINDR
241 RARFPSHEVD SSRETGHSPD RRYAMVLFRI TSVFYMLWLP YIIYFLLESS RVLDNPTLSF
301 LTTWLAISNS FCNCVIYSLS NSVFRLGLRR LSETMCTSCM CVKDQEAQEP KPRKRANSCS
361 ILocalizationUniProt · AlphaFold · HPA
Whether an antibody against GPR52 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 5.1 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 5.1 nTPM
- cerebral cortex: 1.3 nTPM
- pituitary gland: 0.6 nTPM
- hypothalamus: 0.5 nTPM
- bone marrow: 0.4 nTPM
- stomach: 0.2 nTPM
Single-cell type
- pancreatic acinar cells: 0.1 nCPM
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
- adrenal medulla cells: 0 nCPM
- alveolar cells type 1: 0 nCPM
- alveolar cells type 2: 0 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- basal ganglia: 32 nTPM
- cerebellum: 12 nTPM
- choroid plexus: 10 nTPM
- cerebral cortex: 8.3 nTPM
- hypothalamus: 7.5 nTPM
- white matter: 5.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.93
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.78
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to light stimulus
- G protein-coupled receptor signaling pathway
- locomotory behavior
- phototransduction
- response to xenobiotic stimulus
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GPR52 as an antibody target. Whether an autoantibody or antibody against GPR52 could matter depends on whether native GPR52 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GPR52 is annotated at the cell surface, where native GPR52 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GPR52 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...